Hematology/Oncology

Top Story

Radiopaque bead treatment at Mount Sinai ‘potential game-changer’ for hepatocellular carcinoma

Radiopaque bead treatment at Mount Sinai ‘potential game-changer’ for hepatocellular carcinoma
May 3, 2016

An estimated 746,000 deaths occur annually from liver cancer worldwide.

Few surgical options are considered beneficial in patients with intermediate- or advanced-stage disease, making it a difficult-to-treat cancer.

In the Journals

Trastuzumab underutilized among older, black women with HER-2–positive breast cancer

May 3, 2016
Approximately half of women aged 65 years or older with early-stage, HER-2–positive breast cancer did not receive targeted therapy with trastuzumab, according to…
Meeting News Coverage

Nucleos(t)ide therapy for HBV does not increase risk for all cancers

May 3, 2016
BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive long-term treatment with…
At IssueVideo

VIDEO: Progress in MRD testing poised to further improve patient outcomes in myeloma

May 3, 2016
C. Ola Landgren, MD, PhD, chief of the myeloma service at the Memorial Sloan Kettering Cancer Center in New York City, discusses the advances in outcomes in multiple…
Meeting News CoverageVideo

VIDEO: Entrectinib safely, effectively treats gene-mutated cancers

May 2, 2016
NEW ORLEANS — Alexander Drilon, MD, assistant attending physician with the developmental therapeutics clinic and thoracic oncology service at Memorial Sloan…
More News Headlines »
CME

The Patient with Non-Small Cell Lung Cancer

No commercial support for this activity.

The management of non-small cell lung cancer (NSCLC) has evolved in the past decade, as advances are made in diagnosis…
More »
Video
Meeting News Coverage

VIDEO: Multivitamin use before breast cancer diagnosis may reduce peripheral neuropathy risk

April 28, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan